Straits Times Index
3,300.04 -3.15 (-0.10%) S&P 500
5,190.97 +10.23 (+0.20%) Dow
38,957.78 +105.51 (+0.27%) Nasdaq
16,356.07 +6.82 (+0.04%) Bitcoin USD
63,345.75 -744.49 (-1.16%) CMC Crypto 200
1,311.06 -54.07 (-3.96%)
ProPhase Labs, Inc. (PRPH)
| Previous close | 5.34 |
| Open | 5.47 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 5.12 - 5.36 |
| 52-week range | 4.05 - 9.94 |
| Volume | |
| Avg. volume | 54,801 |
| Market cap | 98.445M |
| Beta (5Y monthly) | -0.27 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 24 May 2022 |
| 1y target est | N/A |
- GlobeNewswire
PROPHASE LABS INC. TO PRESENT FIRST QUARTER 2024 FINANCIAL RESULTS ON MAY 9
GARDEN CITY, NY, May 02, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ: PRPH), announced today that they will be presenting first quarter 2024 financial results on a virtual conference call hosted by Renmark Financial on May 9, 2024 at 11:00 am EDT. A press release detailing these results will be issued prior to the virtual conference call. ProPhase Labs Inc. welcomes stakeholders, investors, and other individual followers to register and attend this live event. Investors interested in par
- GlobeNewswire
ProPhase Labs to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024
Garden City, NY, April 25, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a biopharma, genomics and diagnostics Company, today announced that it will be presenting at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 at 11:30 am PST, 2:30 pm EST. Ted Karkus, CEO, will be hosting the presentation and answering questions at the conclusion. To access the live presentation, please use the following information: Planet MicroCap Showcase: VEGAS 2024Date: Wednesday, May 1
- GlobeNewswire
Diamond Equity Research Releases Update Note on ProPhase Labs Inc. (NASDAQ: PRPH)
NEW YORK, April 23, 2024 (GLOBE NEWSWIRE) -- Diamond Equity Research, a leading equity research firm with a focus on small capitalization public companies has released an Update Note on ProPhase Labs Inc. (NASDAQ: PRPH). The update note includes information on the ProPhase’s business model, services, industry, financial results, valuation, and risks. The update note is available here. Highlights from the note include: ProPhase Labs Advances Cancer Treatment with Project ZenQ-AI - ProPhase Labs h
